SCHEMBL16703966

SCHEMBL16703966

CC(=O)Nc1ncnn2c(C3OC(C#N)(CO[Si](C)(C)C(C)(C)C)[C@H]4OC(C)(C)OC34)cc(F)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20943580 1.00 — —
SCHEMBL16701322 0.91 — —
SCHEMBL19101771 0.88 EGLN2 (0.32) —
SCHEMBL20943594 0.87 TMPRSS2 (0.33) —
SCHEMBL30873318 0.85 — —
SCHEMBL16698825 0.81 TMPRSS2 (0.33) —
SCHEMBL19778893 0.79 EGLN2 (0.33) —
SCHEMBL19101821 0.78 — —
SCHEMBL30873302 0.78 — —
SCHEMBL25386594 0.76 TMPRSS2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068405-A1 PYRROLO [1,2,F][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2016-09-21 — — EP disclosed
WO-2015069939-A1 PYRROLO [1,2,F] [1,2,4] TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS GILEAD SCIENCES, INC. (US) 2015-05-14 — — WO disclosed
Send feedback